Bevacizumab (Rhumab Vegf)


Combined with:

Eloxatin
Fluorouracil
Leucovorin Calcium

Indications and Reactions:

Role Indications Reactions
Primary
Colorectal Cancer 100.0%
Pulmonary Embolism 29.5%
Vomiting 9.5%
Abdominal Pain 7.4%
Large Intestine Perforation 5.3%
White Blood Cell Count Decreased 5.3%
Haemorrhage 4.2%
Pneumonia 4.2%
Blood Pressure Increased 3.2%
Hypertension 3.2%
Pulmonary Haemorrhage 3.2%
Pyrexia 3.2%
Syncope 3.2%
Unresponsive To Stimuli 3.2%
Venous Thrombosis 3.2%
Acute Respiratory Failure 2.1%
Cardiac Arrest 2.1%
Completed Suicide 2.1%
Deep Vein Thrombosis 2.1%
Dehydration 2.1%
Fall 2.1%
Secondary
Colorectal Cancer 100.0%
Vomiting 18.3%
Pulmonary Embolism 10.0%
Urinary Tract Infection 10.0%
Diarrhoea 6.7%
Pyrexia 5.8%
Fatigue 4.2%
Hypokalaemia 4.2%
Nausea 4.2%
Renal Failure 4.2%
Weight Decreased 4.2%
White Blood Cell Count Decreased 4.2%
Abdominal Pain 3.3%
Neuropathy Peripheral 3.3%
Deep Vein Thrombosis 2.5%
Febrile Neutropenia 2.5%
Ileus Paralytic 2.5%
Malaise 2.5%
Neutrophil Count Decreased 2.5%
Pneumonia 2.5%
Sepsis 2.5%

Drug Data